Papers on Evans Blue Dye for human use

These papers have been souced from many publications and are catalogued from the latest to the first. Many have been supplied by the authors and we welcome additions. They are available to our customers at photocopying time and postage costs only as part of our service. We cannot make them available to none clients, who should source them directly frpm the publications.

A search may be done on specific words by using your browser find button

PAPERS

74. INHIBITION OF THE BINDING OF HIV rgp120 TO CD4 BY DYES. Weaver J.L. Pine P.S. Anand RBell S. Aszalos A. Antiviral Chemistry and Chemotherapy*****3 (3) 147-151. 1992

73. EFFECT OF EVANS BLUE AND TRYPAN BLUE ON SYNCYTIA FORMATION AND INFECTIVITY OF HIV TYPE 1 AND TYPE 11 IN VITRO. Pal R. Mumbauer S. Hoke G. Larocca R. Myers C. Sarngadharan M.G. Stein C.A. Aids Research and Human Retroviruses***** Vol. 7. No 6. 1991

72. POLYIONIC COMPOUNDS SELECTIVELY ALTER AVAILABILITY OF CD4 RECEPTORS FOR HIV COAT PROTEIN rgp120. Weaver J.L. Gergely P. Pine P.S. Patzer E. Aszalor A. Aids Research and Human Retroviruses*****Vol 6 No 9. 1990.

71. DIFFERENTIAL INHIBITORY EFFECTS OF EVANS BLUE ON VARIOUS DNA POLYMERASES. Nakane H. Balzarini J. De Clercq E. Ono K. Nucleic Acids Research*****Series No 17, 1986.

70. COMPARATIVE INHIBITORY EFFECTS OF SURAMIN AND OTHER SELCTED COMPOUNDS ON THE INFECTIVITY AND REPLICATION OF HUMAN T- CELL LYMPHOTROPIC VIRUS. Balzarini J. Mitsuya H. De Clercq E. Broder S. International Journal of Cancer***** 37. 451-457. 1986.

69. AURINTRICARBOXYLIC ACID AND EVANS BLUE REPRESENT TWO DIFFERENT CLASSES OF ANIONIC COMPOUNDS SELECTIVELY INHIBIT THE CYTOPATHOGENICITY OF HUMAN T-CELL LYMPHOTORPIC VIRUS . Balzarini J. Mitsuya H. De Clercq E. Broder S. Biochemical and Biophysical Research Communications***** Vole 136. No 1. 1986

68. MAXIMAL AEROBIC CAPACITY AND TOTAL BLOOD VOLUME IN HIGHLY TRAINED MIDDLE-AGED AND OLDER FEMALE ENDURANCE ATHLETES. Stevenson E.T. Davy K.P. Seals D.R. American Physiological Society*****1994

67. TOTAL BLOOD VOLUME IN HEALTHY YOUNG AND OLDER MEN Davy K.P. Seals D.R. American Physiological society*****1994

66. EVANS BLUE DYE AND A MARKER OF ALBUMIN CLEARANCE IN CULTURED ENDOTHELIAL MONOLAYER AND ISOLATED LUNG. Patterson C.E. Rhoades R.A. Garcia J.G.N. American Physiological Society*****1992

65. TOXICOLOGICAL EVALUATION OF EVANS BLUE FOR CREWMEMBER INJECTIONS. James J. National Aeronautics and Space Administraction*****May 1990.

64. RESULTS OF A MEDLINE SEARCH CONCERNING USE OF EVANS BLUE IN PREGNANT WOMEN. Deacon M. NASA. Dec 1992.

63. MEASUREMENT OF PLASMA VOLUME IN PREGNANCY. Brown MA. Mitar DA. Whitworth JA. Clinical Science*****1992 (83) 29-34

62. EXTRACELLULAR FLUID VOLUMES IN PREGNANCY INDUCED HYPERTENSION. Brown MA. Zammit VC. Mitar DA. Journal of Hypertension*****1992 (10) 61-68

61. ACUTE AND CHRONIC REGULATION OF ATRIAL NATRIURITIC PEPTIDE IN HUMAN PREGNANCY: A LONGITUDINAL STUDY. Lowe SA. Macdonald GJ. Brown MA. Journal of Hypertension*****1992 (10) 821-82

60. EVANS BLUE (T-1824) AND ALBUMIN CLEARANCES. Chinard FP. Lauson HD. Eder HA. Journal of Applied Physiology*****1992 Oct;73(4):1694-6

59. EVANS BLUE DYE AS A MARKER OF ALBUMIN CLEARANCE IN CULTURED ENDOTHELIA MONOLAYER AND ISOLATED LUNG. Patterson CE. Rhoades RA. Garcia JGN. Journal of Applied Physiology*****1992: 72: 865-873

58. PLASMA VOLUME, FLUID SHIFTS AND RENAL RESPONSES IN HUMANS DURING 12 HOURS OF HEAD-OUT OF WATER IMMERSION. Johansen LB. Foldager N. Stadeager C. et al. Journal of Applied Physiology*****1992 73(2) 539-544

57. EFFECT OF SHORT TERM MUSCLE RELAXATION ON NEONATAL PLASMA VOLUME. Buckner PS. Todd DA. Lui K. John E.Critical Care Medicine*****1991 Nov;19(11):1357-61

56. EVANS BLUE: DRUGS USED TO DETERMINE BLOOD VOLUME. Diagnostic Drugs****(67) 1274.

55. BODY COMPOSITION, NUTRITION AND FLUID BALANCE DURING THE FIRST TWO WEEKS OF LIFE IN PRETERM NEONATES. Bauer K. Bovermann G. Roithmaier A. Gotz M. Prolss A. Versmold HT. Journal of Pediatrics*****1991 Apr 615-620

54. BLOOD AND PLASMA VOLUMES DETERMINED BY CARBON MONOXIDE GAS, 9mTc-lABELLED ERYTHROCYTES, 125I--LBUMIN AND EVANS BLUE TECHNIQUE. Thomsen JK. Fogh-Andersen N. Bulow K. Devantier A. Scandinavian Journal of Clinical Laboratory Investigation*****1991 Apr;51(2):185-90

53. CARDIOGENIC DISORDERS OF THE SYSTEMIC HEMODYNAMICS IN LESIONS OF THE MAJOR CEREBRAL ARTERIES. Ishchenko MM. Dorogii AN. Nechai EE. Shkrobot SI. Vrach Delo*****1991 (Russian: abstract only in English)

52. REPEATED PLASMA VOLUME DETERMINATION WITH THE EVANS BLUE DYE DILUTION TECHNIQUE: The method and a computer program. Foldager N. Blomqvist CG. Computers in Biological Medicine*****1991: 21 (172) 35-41

51. GENETIC AMNIOCENTESIS IN MULTIPLE GESTATION: A NEW TECHNIQUE TO DIAGNOSE MONOAMNIOTIC TWINS. Tabsh K. Obstetrics and gynecology***** 1990 Feb;75(2):296-8

50. MEASUREMENT OF CIRCULATING PLASMA VOLUME BY EVANS BLUE INDICATOR. Datsenko BM. Pilipenko HI. Gubsky VI. Sherlanov RA. biochemistry****Authors collective Kharkov Ukraine 1990.

49. GREEN BABY: A CONSEQUENCE OF INTRAUTERINE EXPOSURE TO EVANS BLUE. Giacoia GP. American Journal of Perinatology*****1988 Jul;5(3):234-5

48. INTRAGESTRIC ACCUMULATION OF EVANS BLUE AS A METHOD FOR ASSESSING ASPIRIN INDUCED ACUTE GASTRIC MUCOSAL INJURY IN HUMANS. Woods KL. Smith JL. Graham DY. Digestive Diseases and Sciences****1988 Jul;33(7):769-73

47. TISSUE ELASTANCE AND FLUID CONDUCTION IN NORMOTENSIVE AND HYPERTENSIVE INTRACEREBRAL MASS HAEMATOMAS. Wallenfang T. Fries G. Ulrich P. Jantzen JP. Acta Neurochirurgica*****(Wien) 1988;95(1-2):28-33

46. MICROMETHOD FOR THE ANALYSIS OF EVANS BLUE IN PLASMA USING ION�PAIR HIGH PERFORMANCE LIQUID CHROMATOGRAPHY. Gardner MJ. Journal of Chromatography*****1986 Sep 5;381(2):295-303

45. GROWTH OF HUMAN LUNG TUMOR IN THE BRAIN OF THE NUDE RAT AS A MODEL TO EVALUATE ANTITUMOR AGENT DILIVERY ACROSS THE BLOOD BRAIN BARRIER. Neuwelt EA. Frenkel EP. D'Agostino AN. Carney DN. Minna JD. Barnett PA. McCormick CI. Cancer Research*****1985 Jun;45(6):2827-33

44. PLASMA VOLUME METHODOLOGY: EVANS BLUE, HEMOGLOBIN-HEMATOGRIT, AND MASS DENSITY TRANSFORMATIONS. Greenleaf JE. Hinghofer-Szalkay H. NASA Technical memorandum******1985

43. THE PATHOGENETIC AND PROGNOSTIC SIGNIFICANCE OF BLOOD BRAIN BARRIER DAMAGE AT THE ACUTE STAGE OF ANEURYSMAL SUBARACHNOID HAEMORRHAGE. Doszi T. Acta Neurochoruggica*****(Wien) 1985;77(3-4):110-32

42. WIDER POTENTIALS FOR DETERMINING THE CIRCULATING BLOOD VOLUME IN CLINICAL PRACTICE. Shanin SS. Gubin VV. Vestn Khir*****1985 (Russian: abstract only in English)

41. EVANS BLUE DISAPPEARANCE RATE IN NORMAL AND PRE ECLAMPTIC PREGNANCY. Campbell DM. Campbell AJ. Clinical and Experimantal Hypertansion*****1983;2(1):163-9

40. A SIMPLE FLUORESCENCE TECHNIQUE TO STAIN THE PLASMA MEMBRANE OF HUMAN NEUTROPHILS. Hed J. Dahlgren C. Rundquist I. Histochemistry*****1983;79(1):105-10

39. RAPID MICROMETHOD FOR THE DETERMINATION OF EVANS BLUE IN HUMAN PLASMA BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY. Green TP. Marchessault RP. Journal of Chromatography*****1983 Apr 8;273(2):426-30

38. COLD TREATMENT FOR BURNS Pushkar NS. Sandorminsky BP. Burns, Including thermal injury*****1982 Nov;9(2):101-10

37. AN IMPROVED METHOD FOR THE DETERMINATION OF THE PLASMA VOLUME WITH EVANS BLUE. Zweens J. Frankena H. Journal of Clinical Chemistry and Biochemistry*****1981Sep;19(9):919-24

36. MORPHOLIGIC STUDY ON THE INTERACTION BETWEEN THE BLOOD VESSEL WALL AND BLOOD FLOW: THE ARTERIAL BRANCHING OSTIUM AND THE SITE OF PERMEABILITY. Tanimura A. Cho T. Nakashima T. Angiology*****1980 Aug;31(8):558-65

35. DERMATITIS ASSOCIATED WITH EVANS BLUE DYE. Lupton GP. Odom RB.Contact Dermatitis*****1980 Oct;6(6):425-9 (abstract only)

34. EVANS BLUE DERMATITIS. Marshall A. Guill MC. Richard B. Odom MC. Arch Dermatology *****1979 Sept; Vol 115

33. THROMBOTIC THROMBOCYTOPENIC PURPURA AND DOSE OF PLASMA EXCHANGE. Taft EG. Blood*****1979 Oct;54(4):842-9

32. PLASMA VOLUME DURING STRESS IN MAN: OSMOLALITY AND RED CELL VOLUME. Greenleaf JE. Convertino VA. Mangseth GR. Journal of Applied Physiology*****1979 47 (5) 1031-1038

31. ULTRASTRUCTURAL STUDIES ON BLOOD BRAIN BARRIER DYSFUNCTION AROUND CEREBRAL STAB WOUNDS AGGRAVATED BY ACUTE ETHANOL INTOXICATION. Persson LI. Rosengren LE. Hansson HA. Acta Neurological Scandinavica****1978 May;57(5):405-17

30. THE DISTRIBUTION OF PLASMA ALBUMIN AS DETERMINED BY EVANS BLUE DYE AND HUMAN SERUM ALBUMIN. Firrell JC. Lewis GP. Youlten LJ.Journal of Physiology*****(Lond) 1978 May;278:18P

29. INJECTION MAMMOGRAPHY. Wayne RW. Darby RE.Jama*****1977 May 16;237(20):2219-20

28. PLASMA VOLUME ESTIMATION IN SEVERELY ILL INFANTS AND CHILDREN USING A SIMPLIFIED EVANS BLUE METHOD. Linderkamp O. Mader T. Butenandt O. Riegel KP. European Journal of Pediatrics*****1977 Jun 1;125(2):135-41

27. THE MORPHOLOGICAL APPROACH TO THE STUDY OF NORMAL AND ABNORMAL BRAIN PERMEABILITY. Brightman MW. Broadwell RD.Advances in Experimental Medicine and Biology*****1976;69:41-54

26. IMMUNOFLUORESCENCE TECHNIQUE WITH COUNTERSTAIN ON FIXED CELLS FOR THE DETECTION OF ANTIBODIES TO HUMAN HERPESVIRUSES: Hilgers F. Hilgers J. Intervirology*****1976;7(6):309-27

25. EVANS BLUE: A SPECIFIC INHIBITOR OF FACTOR VIII�INDUCED PLATELET AGGLUTINATION. Kirby EP. Thrombosis et Diathesis Haemorrhagica*****1975 Dec 15;34(3):770-9

24. EVANS BLUE: CHEMICAL AND PHYSICAL DATA. IARC*****1974. 151-156

23. EVANS BLUE AS A COUNTERSTAIN IN THE DEMONSTRATION OF MUSCLE ANTIBODIES BY IMMUNOFLUORESCENCE IN MYASTHENIA GRAVIS. Closs O. Aarli JA. Journal of Clinical Pathology*****1974 Feb;27(2):162-7 75017001

22. TOXICOLOGICAL EFFECTS OF EVANS BLUE AND CONGO RED ON BLOOD PLATELETS. Giger M. Baumgartner HR. Zbinden G. Agents and Actions*****1974 Aug;4(3):173-80

21. A RAPID PROCEDURE FOR TESTING THE INTEGRITY OF THE MATERNAL FETAL BARRIER IN SPONTANEOUSLY DELIVERED PLACENTAS. Lemtis H. Kirchner H. Journal of Perinatal Medicine*****1974;2(2):130-4

20. PLASMA VOLUME DECREASE AND ELEVATED EVANS BLUE DISAPPEARANCE RATE IN ESSENTIAL HYPERTENSION. Ulrych M. Clinical Science and Molecular Medicine. Supplement*****1973Aug;42(2):173-81

19. BODY WATER COMPARTMENTS DURING BED REST: EVALUATION OF ANALYTINCAL METHODS. Young HL. Juhos L. Castle BL. Yusken J. Greenleaf JE. NASA technical report*****May 1972

18. INTRA�AMNIOTIC INJECTION OF EVANS BLUE DYE. Morrison L. Wiseman HJ.American Journal of Obstetrics and Gynecology*****1972 Aug 15;113(8):1147

17. A FURTHER STUDY ON THE TRANSMISSION OF DYES ACROSS THE PLASMA ASCITIC FLUID BARRIER. (Fluorescein and Evans Blue) Arab MM. Mehanna M. Zein MS. Dorry K. Arzneimittel�Forschung*****1973 Sep;23(9):1351-3

16. PREMATURE RUPTURE OF THE FETAL MEMBRANES CONFIRMED BY INTRA�AMNIOTIC INJECTION OF EVANS BLUE DYE. Atlay RD. Sutherst JR. American Journal of Obstetrics and Gynecology*****1970 Nov 15;108(6):993-4

15. BLOOD VOLUME CHANGES AND BLOOD LOSS ASSOCIATED WITH LABOR. CORRELATION OF CHANGES IN BLOOD VOLUME MEASURED BY I-131 ALBUMIN AND EVANS BLUE, WITH MEASURED BLOOD LOSS. Quinlivan WL. Brock JA.American Journal of Obstetrics and Gynecology*****1970 Mar 15;106(6):843-9

14. MEASUREMENT OF PLASMA VOLUME BY MEANS OF 59Fe-LABELLED DEXTRAN AND EVANS BLUE COMPARED. Wilson RJ. Mills IH.Journal of Clinical Pathology*****1970 May;23(4):286-90

13. EQUILIBRIUM AND KINETIC PROPERTIES OF THE EVANS BLUE-ALBUMIN SYSTEM. Freedman FB. Johnson JA. American Journal of Physiology*****1969 Mar;216(3):675-81

12. CARDIAC OUTPUT MEASUREMENT BY CONTINUOUS INFUSION OF RADIO IODINATED SODIUM HIPPURATE INTO THE LEFT VERTRICLE. COMPARISON WITH EVANS BLUE AND WITH THE FICK PRINCIPLA IN MAN . Strangfeld D. Gunther KH. Porstmann W. Cardiology*****1969;54(5):262-70

11. TERATOGENIC ACTIVITY OF SIX DISAZO DYES IN THE WISTAR ALBINO RAT. Beaudoin AR. Proc Society of Experimental Biology*****1968 127: 215-9

10. TOXICITY OF TWO VITAL DYES USED IN PLASMA VOLUME DETERMINATION. Gibson JG. Gregersen MI. American Physiological Society

9. THE DETERMINATION OF PLASMA VOLUME USING COOMASSIE BLUE DYE AS INDICATOR. A COMPARISON OF THE VALUES IN THE SAME INDIVIDUALS USING EVANS BLUE DYE AND RADIOIODINATED ALBUMIN . Martin WB. Koch GF. Diseases of the Chest*****1967 Oct;52(4):525-30

8. DIFFUSION OF GLUCOSE, INSULIN, INULIN AND EVANS BLUE PROTEIN INTO THORACIC DUCT LYMPH OF MAN. Rasio EA. Hampers CL. Soeldner JS. Cahill GF Jr. Journal of Clinical Investigation*****1967 Jun;46(6):903-10

7. THE BEHAVIOUR OF EVANS BLUE IN THE BODY AFTER INTRAVENOUS INJECTION. Stoelinga GB. Munster PJ Van. Acta Physiologica et Pharmacologica Needlandica*****Neerl 1967 Dec;14(4):391-409

6. THE CHARACTERIZATION OF CERTAIN ALPHA GLOBULING IN IMMUNOELECTROPHORESIS OF HUMAN SERUM USING EVANS BLUE. Rabinovitz M. Schen RJ. Clinica Chimica Acta*****1967 Sep;17(3):499-503

5. THE AFFINITY OF EVANS BLUE FOR THE ALPHA-1-LIPOPROTEIN OF HUMAN SERUM. Schen RJ. Rabinovitz M. Goldschmid A. Tenne M. Clinica Chimica Acta*****1967 Jun;16(3):445--8

4. RAPID ELIMINATION OF EVANS BLUE IN AMYLOIDOSIS. Abildgaard U.Acta Medica Scandinavica*****1966 Dec;180(6):709-14

3. CLINICAL STUDIES OF BLOOD VOLUME. CLINICAL APPLICATION OF METHODS EMPLOYING AZO BLOOD "EVANS BLUE" AND SPECTROPHOTOMETER. Gibson JG. Evans WA Jnr. Journal of Clinical Investigation****1937: 16, 301

2. BLOOD VOLUME STUDIES: BEHAVIOUR OF LARGE SERIES OF DYES INTRODUCED INTO CIRCULATING BLOOD. Dawson AB. Evans HM. Whipple GH. American Journal of Physiology*****1920: 51, 232

1. A METHOD FOR THE DETERMINATION OF PLASMA AND BLOOD VOLUME.Keith NM. Rowntree LG. Geraghty JT. Archives of Internal Medicine*****1915: 547-557.